Related Experiment Videos

Insulin and glucagon response to arginine infusion in cystic fibrosis

Insights

Children with cystic fibrosis (CF) show reduced insulin secretion. Glucagon responses vary, with some severe cases exhibiting high levels potentially from stress or extrapancreatic sources.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Disorders

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas.
  • Pancreatic dysfunction in CF can impact hormone secretion, affecting glucose metabolism.
  • Understanding hormonal responses in CF is crucial for managing associated complications.

Purpose of the Study:

  • To investigate the glucagon and insulin responses to intravenous arginine in children with cystic fibrosis.
  • To compare these hormonal responses with those in healthy control children.
  • To correlate hormonal secretion patterns with disease severity in cystic fibrosis.

Main Methods:

  • Studied 17 children with cystic fibrosis and 9 control children.
  • Administered intravenous arginine to stimulate hormone release.
  • Measured glucagon and insulin levels in response to arginine challenge.

Main Results:

  • Overall diminished insulin secretion was observed in children with cystic fibrosis.
  • Glucagon responses were variable: seven normal, four excessively high, and six low.
  • Four children with severe CF and high glucagon output also had fasting hypoglycemia and low insulin response.

Conclusions:

  • Confirmed diminished insulin secretion in cystic fibrosis.
  • Diminished glucagon secretion was noted only when some insulin secretion was preserved.
  • High glucagon levels in insulin-deficient CF patients may be extrapancreatic or stress-related, possibly linked to severe pulmonary involvement.

Related Concept Videos